DE69932592D1 - Rekombinante proteine abgeleitet von hgf und msp - Google Patents

Rekombinante proteine abgeleitet von hgf und msp

Info

Publication number
DE69932592D1
DE69932592D1 DE69932592T DE69932592T DE69932592D1 DE 69932592 D1 DE69932592 D1 DE 69932592D1 DE 69932592 T DE69932592 T DE 69932592T DE 69932592 T DE69932592 T DE 69932592T DE 69932592 D1 DE69932592 D1 DE 69932592D1
Authority
DE
Germany
Prior art keywords
recombinant proteins
msp
hgf
proteins derived
deriving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69932592T
Other languages
English (en)
Other versions
DE69932592T2 (de
Inventor
Enzo Medico
Paolo Michieli
Chiara Collesi
Gianfranco Caselli
Paolo Comoglio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dompe SpA
Original Assignee
Dompe PhaRMa SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe PhaRMa SpA filed Critical Dompe PhaRMa SpA
Publication of DE69932592D1 publication Critical patent/DE69932592D1/de
Application granted granted Critical
Publication of DE69932592T2 publication Critical patent/DE69932592T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69932592T 1998-01-30 1999-01-27 Rekombinante proteine abgeleitet von hgf und msp Expired - Lifetime DE69932592T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI980179 1998-01-30
IT98MI000179A ITMI980179A1 (it) 1998-01-30 1998-01-30 Proteine ricombinanti derivate da hgf e msp
PCT/EP1999/000478 WO1999038967A2 (en) 1998-01-30 1999-01-27 Recombinant proteins derived from hgf and msp

Publications (2)

Publication Number Publication Date
DE69932592D1 true DE69932592D1 (de) 2006-09-14
DE69932592T2 DE69932592T2 (de) 2007-08-09

Family

ID=11378771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69932592T Expired - Lifetime DE69932592T2 (de) 1998-01-30 1999-01-27 Rekombinante proteine abgeleitet von hgf und msp

Country Status (14)

Country Link
US (1) US6551991B1 (de)
EP (1) EP1049778B1 (de)
JP (1) JP4478329B2 (de)
AT (1) ATE335080T1 (de)
AU (1) AU740490B2 (de)
CA (1) CA2319211C (de)
DE (1) DE69932592T2 (de)
ES (1) ES2270581T3 (de)
HU (1) HU226717B1 (de)
IL (2) IL137564A0 (de)
IT (1) ITMI980179A1 (de)
NZ (1) NZ506005A (de)
WO (1) WO1999038967A2 (de)
ZA (1) ZA99723B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004032847A2 (en) * 2002-10-07 2004-04-22 Genentech, Inc. Hepatocyte growth factor variants
JP4563937B2 (ja) * 2003-06-06 2010-10-20 敏一 中村 細胞含有製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
WO1993023541A1 (en) * 1992-05-18 1993-11-25 Genentech, Inc. Hepatocyte growth factor variants
EP0642585B1 (de) * 1992-05-18 2005-12-28 Genentech, Inc. Aktivierung von Rezeptoren fähig zur Oligomerisierung durch Verwendung von fusionierten Rezeptor Liganden
DE69310525T2 (de) * 1992-09-16 1997-10-02 Genentech Inc Schutz gegen leberschäden mit hgf

Also Published As

Publication number Publication date
ATE335080T1 (de) 2006-08-15
EP1049778A2 (de) 2000-11-08
CA2319211A1 (en) 1999-08-05
AU740490B2 (en) 2001-11-08
WO1999038967A2 (en) 1999-08-05
HUP0104598A1 (hu) 2002-03-28
ZA99723B (en) 1999-07-29
IL137564A (en) 2007-06-17
NZ506005A (en) 2003-06-30
ITMI980179A1 (it) 1999-07-30
JP2002501745A (ja) 2002-01-22
US6551991B1 (en) 2003-04-22
CA2319211C (en) 2010-10-26
AU2424599A (en) 1999-08-16
DE69932592T2 (de) 2007-08-09
HUP0104598A3 (en) 2003-09-29
JP4478329B2 (ja) 2010-06-09
IL137564A0 (en) 2001-07-24
ES2270581T3 (es) 2007-04-01
HU226717B1 (en) 2009-07-28
EP1049778B1 (de) 2006-08-02
WO1999038967A3 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
ATE251140T1 (de) N-(2 oxoacetyl oder sulphonyl)- pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
DE59709437D1 (de) Neue phenanthridine
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
DE69533551D1 (de) Camptothecin arzneimittelkombinationen mit verringerten nebenwirkungen
DE59903921D1 (de) Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
DK0839154T3 (da) Biologiske aktive peptider og præparater samt anvendelse deraf
TR200101549T2 (tr) p53-Familyasından bir proteinin yapısal kararlılığının canlandırılmasına yönelik metotlar.
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
ATE188256T1 (de) Oberflächenlokalisierte expression von enzymen in gengesteuerter prodrugtherapie
EA200600424A1 (ru) Применение полипептидов семейства купредоксинов при лечении рака
DE69940980D1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
BR9808221A (pt) Método de tratamento de tumor.
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
ATE162078T1 (de) Morphogeninduzierte regenerierung der leber
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ATE335080T1 (de) Rekombinante proteine abgeleitet von hgf und msp
ATE232398T1 (de) Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid
DK0671909T3 (da) Syndecanstimulering af cellulær differentiering
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition